News

Nurofen advertisement was misleading, says watchdog

BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i3669 (Published 30 June 2016) Cite this as: BMJ 2016;353:i3669
  1. Clare Dyer
  1. The BMJ

The UK advertising watchdog has banned a TV advertisement because it misled consumers by suggesting that Reckitt Benckiser’s branded ibuprofen product, Nurofen Joint and Back Pain Relief, could target particular areas of the body.

In a decision that could signal a crackdown on the marketing of general painkillers for specific purposes, the Advertising Standards Authority (ASA) ruled that the ad was misleading because it “implied that the product had a special mechanism which meant it specifically targeted back and joint pain, and was especially effective at relieving those sources of …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe